RonaldWayneTakvorianMD

PubMed

• Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.
  Ahn, I., Brander, D., Ren, Y., Zhou, Y., Tyekucheva, S., Walker, H., Black, R., Montegaard, J., Alencar, A., Shune, L., Omaira, M., Jacobson, C., Armand, P., Ng, S., C...> ;Blood Advances. 2024 Feb 27
• 2 citations
  Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma.
  Reem Karmali, Jeremy S Abramson, Shuo Ma, Juehua Gao, Adam M Petrich, Deborah M Stephens, Jeffrey Barnes, Jane N Winter, Jason Kaplan, Ephraim Hochberg, Tak Takvorian,...> ;Blood Advances. 2023 Dec 12
• Metabolic parameters predict survival and toxicity in chimeric antigen receptor T-cell therapy-treated relapsed/refractory large B-cell lymphoma.
  Hazim S Ababneh, Andrea K Ng, Jeremy S Abramson, Jacob D Soumerai, Ronald W Takvorian, Matthew J Frigault, Chirayu G Patel> ;Hematological Oncology. 2024 Jan 1
• 2 citations
  Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
  Philipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, Deborah A Forst, Elizabeth Gerstner, Justin T Jordan, Ina Ly, Scott R Plotkin, Nancy Wang, Maria Martinez-...> ;Neuro-Oncology. 2023 Dec 8
• 1 citations
  Venetoclax activity in a patient with central nervous system involvement by chronic lymphocytic leukaemia.
  Jacob D Soumerai, Ronald W Takvorian, Aliyah R Sohani, Jeremy S Abramson, Judith A Ferry> ;The Lancet. Haematology. 2022 Oct 1
• 30 citations
  Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma.
  Jeremy S. Abramson, Jon E. Arnason, Ann S. LaCasce, Robert A. Redd, Jeffrey A. Barnes, Lubomir Sokol, Robin Joyce, David Avigan, Donna Neuberg, Ronald W. Takvorian, Ep...> ;Blood. 2019 Aug 15
• 52 citations
  Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, ph...
  Matthew S. Davids, Danielle M. Brander, Haesook T. Kim, Svitlana Tyekucheva, Alexandra Savell, Jeffrey M Hellman, Josie Bazemore, Karen Francoeur, Alvaro J. Alencar, L...> ;The Lancet. Haematology. 2019 Aug 1
• 177 citations
  Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells
  Philipp Karschnia, Justin T. Jordan, Deborah Forst, Isabel Arrillaga-Romany, Tracy T. Batchelor, Joachim M. Baehring, Nathan F. Clement, L. Nicolas Gonzalez Castro, Al...> ;Blood. 2019 May 16
• Case 28-2018: A 39-Year-Old Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia
  Christiana Iyasere, Ronald W. Takvorian, F. Joseph Simeone, Bradford Siegele> ;The New England Journal of Medicine. 2018 Sep 12
• 4 citations
  Rare presentation of secondary cutaneous involvement by splenic marginal zone lymphoma: report of a case and review of the literature.
  Jeffrey M. Cohen, Rosalynn M. Nazarian, Judith A. Ferry, Ronald W. Takvorian, Joi B. Carter> ;The American Journal of Dermatopathology. 2015 Jan 1
• 65 citations
  Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary re...
  Jacob D. Soumerai, Matthew D Hellmann, Yang Feng, Aliyah R. Sohani, Christiana E. Toomey, Jeffrey A. Barnes, Ronald W. Takvorian, Donna Neuberg, Ephraim P. Hochberg, J...> ;Leukemia & Lymphoma. 2014 Mar 1
• 14 citations
  Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patien...
  Yi Bin Chen, Shuli Li, David C. Fisher, Jessica Driscoll, Candice Del Rio, Jeremy S. Abramson, Philippe Armand, Jeffrey A. Barnes, Jennifer R. Brown, Corey Cutler, Are...> ;Biology of Blood and Marrow Transplantation. 2014 Feb 1
• 7 citations
  Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study.
  Jeremy S. Abramson, Ronald W. Takvorian, David C. Fisher, Yang Feng, Eric D. Jacobsen, Jennifer R. Brown, Jeffrey A. Barnes, Donna Neuberg, Ephraim P. Hochberg> ;Leukemia & Lymphoma. 2013 Jan 4
• Pathology quiz case 1. Diffuse large B-cell lymphoma (DLBCL) of the thyroid.
  Linda N. Lee, Robert P. Hasserjian, William C. Faquin, Ronald W. Takvorian, James W. Rocco> ;Archives of Otolaryngology--Head & Neck Surgery. 2011 Aug 1
• 49 citations
  Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.
  David J. Straus, Jeffrey L. Johnson, Ann S. LaCasce, Nancy L. Bartlett, Lale Kostakoglu, Eric D. Hsi, Heiko Schöder, Nathan Hall, Sin-Ho Jung, George P. Canellos, Lawr...> ;Blood. 2011 May 19
• 40 citations
  Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls
  Evan A. Farkash, Judith A. Ferry, Nancy L. Harris, Ephraim P. Hochberg, Ronald W. Takvorian, Dan S. Zuckerman, Aliyah R. Sohani> ;Journal of Hematopathology. 2009 Aug 20
• 62 citations
  A Phase 2 Study of Concurrent Fludarabine and Rituximab for the Treatment of Marginal Zone Lymphomas
  Jennifer R. Brown, Jonathan W. Friedberg, Yang Feng, Sarah Scofield, Kimberly Phillips, Paola Dal Cin, Robin Joyce, Ronald W. Takvorian, David C. Fisher, Richard I. Fi...> ;British Journal of Haematology. 2009 Mar 30
• 62 citations
  Primary pulmonary lymphoma.
  Brian B. Graham, Douglas J. Mathisen, Eugene J. Mark, Ronald W. Takvorian> ;The Annals of Thoracic Surgery. 2005 Oct 1
• 11 citations
  Results of a Prospective Trial of Mantle Irradiation Alone for Selected Patients With Early-Stage Hodgkin’s Disease
  Kendall H. Backstrand, Andrea K. Ng, Ronald W. Takvorian, Ellen L. Jones, David C. Fisher, Beverly J. Molnar-Griffin, Barbara Silver, Nancy J. Tarbell, Peter Mauch> ;Journal of Clinical Oncology. 2001 Feb 1
• 20 citations
  Pulmonary uptake of technetium 99m macroaggregated albumin: a predictor of gastrointestinal toxicity during hepatic artery perfusion.
  W D Kaplan, Steven E. Come, Ronald W. Takvorian, S M Laffin, Rebecca Gelman, Geoffrey R. Weiss, Marc B. Garnick> ;Journal of Clinical Oncology. 1984 Nov 1
• 26 citations
  Autologous bone marrow transplantation following high-dose chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of curre...
  Rolf A. Stahel, Ronald W. Takvorian, Arthur T. Skarin, George P. Canellos> ;European Journal of Cancer & Clinical Oncology. 1984 Oct 1
• 42 citations
  Radionuclide angiography to predict patient response to hepatic artery chemotherapy.
  Kaplan Wd, Steven E. Come, Smith Eh, Carl J. D'Orsi, Levin Dc, Ronald W. Takvorian, Glenn Steele> ;Cancer Treatment Reports. 1980 Jan 1
• Join now to see all

Abstracts/Posters

• Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD Evaluation
  Ronald W. Takvorian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018